Jatin Gajjar serves as the Chief Technology Officer of Senores Pharmaceuticals Limited, bringing over three decades of leadership experience in pharmaceutical technology, manufacturing operations and product development.

His expertise is in complex formulations, regulatory compliance & process optimization. He has played a pivotal role in advancing complex generics, injectable formulations and novel drug delivery technologies while enabling regulatory approvals and commercialization across key markets. At Senores, he provides strategic leadership, across R&D, manufacturing and RA, aligning technology with our business goals, further improving efficiency and embedding a culture of innovation and scientific excellence.

Previously, Jatin served as President at QuoSolve Pharmaceutical Consultants and held leadership roles at global pharma organizations including Amneal Pharmaceuticals, Sun Pharmaceutical Industries, Alembic, Zydus Cadila, Torrent Pharma and Aventis Pharma. He holds both Bachelor’s and Master’s degrees in Pharmacy from L.M. College of Pharmacy, Gujarat University, along with a diploma in Marketing and Sales Management from RPICM, Bharatiya Vidya Bhavan.